Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Fausto Barbieri"'
Autor:
Paolo Cameli, Paola Faverio, Katia Ferrari, Viola Bonti, Stefania Marsili, Maria Antonietta Mazzei, Francesca Mazzoni, Maurizio Bartolucci, Vieri Scotti, Federica Bertolini, Fausto Barbieri, Cinzia Baldessari, Chiara Veronese, Roberto Boffi, Matteo Brighenti, Diego Cortinovis, Massimo Dominici, Alberto Pesci, Elena Bargagli, Fabrizio Luppi
Publikováno v:
Life, Vol 12, Iss 8, p 1149 (2022)
Background: Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic horizons of various cancers. However, immune-related adverse events have been reported, including interstitial lung diseases. Our aim was to describe the clinical and
Externí odkaz:
https://doaj.org/article/ceeaa02fde5741feb0c5e586c950bd99
Autor:
Danilo Rocco, Alex Friedlaender, Alfredo Addeo, Marina Chiara Garassino, Diego Signorelli, Alessandro Russo, Vincenzo Sforza, Alessio Cortellini, Katia Cannita, Daniele Santini, Pietro Di Marino, Federica Zoratto, Marco Russano, Paolo Marchetti, Francesca Rastelli, Rossana Berardi, Rita Chiari, Alain Gelibter, Giampiero Porzio, Paolo Bironzo, Giuseppe L Banna, Joachim GJV Aerts, Fausto Barbieri, Diego L Cortinovis, Francesco Passiglia, Mariangela Torniai, Carlo Genova, Alessandro Inno, Giovanni Mansueto, Fabrizio Citarella, Luca Cantini, Miriam G Ferrara, Lorenza Landi, Luigi Della Gravara, Serena Ricciardi, Alessandro De Toma, Vincenzo Adamo, Alessandro Leonetti, Ettore D'Argento, Erika Rijavec, Annalisa Guida, Marco Siringo, Marianna Macerelli, De Tursi Michele, Antonino Grassadonia, Alessandro Tuzi, Paola Bordi, Gabriele Minuti, Giulio Metro, Gian Paolo Spinelli
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Background Some concomitant medications including antibiotics (ATB) have been reproducibly associated with worse survival following immune checkpoint inhibitors (ICIs) in unselected patients with non-small cell lung cancer (NSCLC) (according to progr
Externí odkaz:
https://doaj.org/article/8143f97c38ab481c9154bd8703e472e1
Autor:
Fabiana Perrone, Giulia Mazzaschi, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Rita Nizzoli, Monica Pluchino, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Federica Bertolini, Fausto Barbieri, Stefania Bettelli, Lucia Longo, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Cancers, Vol 14, Iss 8, p 2019 (2022)
Introduction: BRAF mutation involved 2–4% of lung adenocarcinoma. Differences in clinicopathologic features and patient outcome exist between V600E and non-V600E BRAF mutated NSCLC. Thus, we sought to assess the frequency and clinical relevance of
Externí odkaz:
https://doaj.org/article/24526de529bb4f77aa24fda215647c5e
Autor:
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, Sandro Pignata, Massimo Di Maio, Elena Verzoni, Alberto Clemente, Valentina Guadalupi, Diego Signorelli, Marcello Tiseo, Raffaele Giusti, Marco Filetti, Marilena Di Napoli, Lorenzo Calvetti, Alessandro Cappetta, Paola Ermacora, Diego Zara, Fausto Barbieri, Cinzia Baldessari, Vieri Scotti, Francesca Mazzoni, Antonello Veccia, Pamela Francesca Guglielmini, Marco Maruzzo, Ernesto Rossi, Francesco Grossi, Chiara Casadei, Alessio Cortellini, Francesco Verderame, Vincenzo Montesarchio, Mimma Rizzo, Manlio Mencoboni, Fable Zustovich, Lucia Fratino, Saverio Cinieri, Giorgia Negrini, Maria Banzi, Mariella Sorarù, Paolo Andrea Zucali, Gaetano Lacidogna, Antonio Russo, Nicola Battelli, Giuseppe Fornarini, Claudia Mucciarini, Sergio Bracarda, Andrea Bonetti, Debora Pezzuolo, Lucia Longo, Donata Sartori, Mauro Iannopollo, Luigi Cavanna, Fausto Meriggi, Davide Tassinari, Claudia Corbo, Angela Gernone, Veronica Prati, Simona Carnio, Pasqualina Giordano, Angela Maria Dicorato, Claudio Verusio, Francesco Atzori, Francesco Carrozza, Stefania Gori, Antonino Castro, Sara Pilotto, Vanja Vaccaro, Elisabetta Garzoli, Francesco Di Costanzo, Evaristo Maiello, Roberto Labianca, Carmine Pinto, Michele Tognetto, Sebastiano Buti
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: This prospective, multicentre, observational INVIDIa-2 study is investigating the clinical efficacy of influenza vaccination in advanced-cancer patients receiving immune-checkpoint inhibitors (ICIs), enrolled in 82 Italian centres, from O
Externí odkaz:
https://doaj.org/article/56f65524e4484c51b38e78016965cac1
Autor:
Massimiliano Salati, Cinzia Baldessari, Fiorella Calabrese, Giulio Rossi, Elisa Pettorelli, Giulia Grizzi, Massimo Dominici, Fausto Barbieri
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 3, Pp 615-621 (2018)
Background: Pulmonary sarcomatoid carcinoma is a rare, poorly differentiated, and highly aggressive type of non-small cell lung cancer. High tumor mutational burden and PD-L1 overexpression make it an excellent candidate for immunotherapy. Objectives
Externí odkaz:
https://doaj.org/article/1025b8ab047d469fb941f1c5edb49d78
Autor:
Giorgia Guaitoli, Federica Bertolini, Stefania Bettelli, Samantha Manfredini, Michela Maur, Lucia Trudu, Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Massimo Dominici, Fausto Barbieri
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 23, p 12867 (2021)
ROS proto-oncogene 1 (ROS1) rearrangements are reported in about 1–2% of non-squamous non-small-cell lung cancer (NSCLC). After efficacy of crizotinib was demonstrated, identification of ROS1 translocations in advanced disease became fundamental to
Externí odkaz:
https://doaj.org/article/19d2a7056f50421786e94146a0937a0d
Autor:
Marina Chiara Garassino, Lucio Crinò, Annamaria Catino, Andrea Ardizzoni, Enrico Cortesi, Federico Cappuzzo, Paola Bordi, Luana Calabrò, Fausto Barbieri, Antonio Santo, Giuseppe Altavilla, Francesca Ambrosio, Enrico Mini, Enrico Vasile, Floriana Morgillo, Alessandro Scoppola, Carmelo Bengala, Alessandro Follador, Natale Tedde, Diana Giannarelli, Giuseppe Lo Russo, Fabiana Vitiello
Publikováno v:
Tumor Biology, Vol 40 (2018)
Objectives: Never-smokers may be a distinct subgroup among patients with advanced non-small cell lung cancer, appearing to benefit less from immunotherapy than smokers. We report results from never-smokers enrolled in the Italian cohort of the nivolu
Externí odkaz:
https://doaj.org/article/a35d500325154acd853223249891e33f
Autor:
Giulia Mazzaschi, Fabiana Perrone, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Monica Pluchino, Maria Pia Armillotta, Annalisa Ubaldi, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Stefania Bettelli, Lucia Longo, Federica Bertolini, Fausto Barbieri, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Clinical Lung Cancer. 23:e478-e488
Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible for long time, but new drugs have recently demonstrated promising results. Evidence on the outcome of KRAS-mutant advanced-NSCLC treated with new standard regimens are still scarce. Thus
Autor:
Paolo Bironzo, Laura Melocchi, Valentina Monica, Dario Trebeschi, Fausto Barbieri, Evaristo Maiello, Maria Rita Migliorino, Alessandra Lombardi, Marcello Tiseo, Luisella Righi, Paolo Graziano, Giulio Rossi, Silvia Novello
Publikováno v:
Pathologica. 114:278-287
37 ALK FISH-positive NSCLC cases diagnosed between 2010 and 2015 in 7 Italian centres were investigated with ICH using three different anti-ALK antibodies (ALK1, 5A4 and D5F3). Staining for ALK1 and 5A4 was graded as 0+,1+,2+, and 3+, while the scori
Autor:
Federico Cappuzzo, Lucio Crinò, Gabriella Fontanini, Agnese Proietti, Rossella Bruno, Greta Alì, Emilio Bria, Claudio Verusio, Francesca Mazzoni, Gabriele Minuti, Enrica Capelletto, Francesco Grossi, Fausto Barbieri, Domenico Galetta, Cesare Gridelli, Alessandro Morabito, Gloria Borra, Filippo de Marinis, Diego Luigi Cortinovis, Diana Giannarelli, Laura Bonanno, Angelo Delmonte, Antonio Chella, Claudio Dazzi, Federica D'Incà, Marcello Tiseo, Rita Chiari, Lorenza Landi
Purpose:MET-deregulated NSCLC represents an urgent clinical need because of unfavorable prognosis and lack of specific therapies. Although recent studies have suggested a potential role for crizotinib in patients harboring MET amplification or exon 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6d6151db514789b70a16810282ae9a
https://doi.org/10.1158/1078-0432.c.6527793
https://doi.org/10.1158/1078-0432.c.6527793